HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vernick, J S Search for Related Content PubMed PubMed Citation Articles by Vernick, J S

Lobbying and advocacy for the public's health: what are the limits for nonprofit organizations?

J S Vernick

Department of Health Policy and Management, Johns Hopkins School of Public Health, Baltimore, MD 21205, USA. jvernick@jhsph.edu

Nonprofit organizations play an important role in advocating for the public's health in the United States. This article describes the rules under US law for lobbying by nonprofit organizations. The 2 most common kinds of non-profits working to improve the public's health are "public charities" and "social welfare organizations." Although social welfare organizations may engage in relatively unlimited lobbying, public charities may not engage in "substantial" lobbying. Lobbying is divided into 2 main categories. Direct lobbying refers to communications with law-makers that take a position on specific legislation, and grassroots lobbying includes attempts to persuade members of the general public to take action regarding legislation. Even public charities may engage in some direct lobbying and a smaller amount of grassroots lobbying. Much public health advocacy, however, is not lobbying, since there are several important exceptions to the lobbying rules. These exceptions include "non-partisan analysis, study, or research" and discussions of broad social problems. Lobbying with federal or earmarked foundation funds is generally prohibited.

This article has been cited by other articles:

				J S Vernick Injury Prevention Policy Forum Inj. Prev., December 1, 2006; 12(6): 382 - 384. [Full Text] [PDF]

				R. A. Galer-Unti, M. K. Tappe, and S. Lachenmayr Advocacy 101: Getting Started in Health Education Advocacy Health Promot Pract, July 1, 2004; 5(3): 280 - 288. [Abstract] [PDF]